Cite
Go RC, Shah R, Nyirenda T, et al. Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia. Crit Care Explor. 2021;3(7):e0493doi: 10.1097/CCE.0000000000000493.
Go, R. C., Shah, R., Nyirenda, T., Oe, Y., Sarfraz, K., Panthappattu, J. J., Philip, L., Bheeman, C., Shah, N., Shah, S., Dar, S., Hung, S., Rahman, W., Im, H., Marafelias, M., Omidvari, K., Pradhan, A., Sadikot, S., Rose, K. M., Sperber, S. J., & Josephs, J. (2021). Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia. Critical care explorations, 3(7), e0493. https://doi.org/10.1097/CCE.0000000000000493
Go, Ronaldo C, et al. "Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia." Critical care explorations vol. 3,7 (2021): e0493. doi: https://doi.org/10.1097/CCE.0000000000000493
Go RC, Shah R, Nyirenda T, Oe Y, Sarfraz K, Panthappattu JJ, Philip L, Bheeman C, Shah N, Shah S, Dar S, Hung S, Rahman W, Im H, Marafelias M, Omidvari K, Pradhan A, Sadikot S, Rose KM, Sperber SJ, Josephs J. Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia. Crit Care Explor. 2021 Jul 19;3(7):e0493. doi: 10.1097/CCE.0000000000000493. eCollection 2021 Jul. PMID: 34291223; PMCID: PMC8291358.
Copy
Download .nbib